This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Angus Cowan and Sulphonamide Compounds.
Introduction
Angus Cowan is an inventor associated with Parkville, Australia, and Anaxis Pharma Pty Ltd. His patent work concerns sulphonamide compounds and their potential role in addressing necroptosis and MLKL activity.
Latest Patents
Cowan is associated with 1 patent, titled “Sulphonamide compounds.” The invention describes compounds of formula (I), along with their salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and prodrugs. It also discloses using these compounds to treat necroptosis and/or inhibit MLKL.
Career Highlights
Cowan’s listed patent reflects research into compounds with potential applications in biological pathways involving necroptosis and MLKL. He is associated with Anaxis Pharma Pty Ltd.
Collaborations
Cowan’s listed coworkers include Martin Brzozowski and Guillaume Laurent Lessene.
Conclusion
Angus Cowan’s patent activity centers on sulphonamide compounds and their proposed use in treating necroptosis and inhibiting MLKL.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile